ABT vs SYK — Key Metrics
| Metric | ABT (ABBOTT LABORATORIES) | SYK (STRYKER CORP) |
|---|---|---|
| Price | 98.83 | 275.39 |
| Market Cap | 171.01 Billion | 105.63 Billion |
| P/E (TTM) | 31.88 | 28.27 |
| P/B (Quarterly) | 3.586 | 5.208 |
| P/S (TTM) | 3.67 | 4.09 |
| Net Profit Margin (TTM) | 11.6 | 14.4 |
| Gross Margin (TTM) | 56.6 | 65.0 |
| ROE (TTM) | 10.4 | 16.4 |
| Revenue Growth YoY (TTM) | None | None |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
ABT · ABBOTT LABORATORIES
Outperform
SYK · STRYKER CORP
Underperform
Recommendation Summary
Stock ABT is projected to outperform the market, stock SYK is projected to underperform the market. Upfront Recommendation: ABT.
Financial Metrics
Prices delayed ~15 min
| ABT | Metrics | SYK |
|---|---|---|
| $98.83 | Price | $275.39 |
| — | Market Capitalization | — |
| 31.88 | Price to Earnings Ratio | 28.27 |
| 3.67 | Price to Sales | 4.09 |
| 21.86 | Price to FCF Ratio | 22.47 |
| 6.48 | Price to Gross Profit | 6.29 |
| 54.12 | Price to R&D | 63.71 |
| 6.98 | Price to Current Assets | 7.33 |